Interleukin-1 stimulates catabolism in C2C12 myotubes
Interleukin-1 stimulates catabolism in C2C12 myotubes
复制标题
DOI:
10.1152/ajpcell.00626.2008
复制
发表时间:
2009-09-01
影响因子:
5.5
通讯作者:
Reid, Michael B.
中科院分区:
文献类型:
--
作者:
Li, Wei;Moylan, Jennifer S.;Reid, Michael B.
Li W, Moylan JS, Chambers MA, Smith J, Reid MB. Interleukin-1 stimulates catabolism in C2C12 myotubes. Am J Physiol Cell Physiol 297: C706-C714, 2009. First published July 22, 2009; doi:10.1152/ajpcell.00626.2008.-Interleukin-1 (IL-1) is an inflammatory cytokine that has been linked to muscle catabolism, a process regulated by muscle-specific E3 proteins of the ubiquitin-proteasome pathway. To address cellular mechanism, we tested the hypothesis that IL-1 induces myofibrillar protein loss by acting directly on muscle to increase expression of two critical E3 proteins, atrogin1/muscle atrophy F-box (MAFbx) and muscle RING-finger 1 (MuRF1). Experiments were conducted using mature C2C12 myotubes to eliminate systemic cytokine effects and avoid paracrine signaling by nonmuscle cell types. Time-course protocols were used to define the sequence of cellular responses. We found that atrogin1/MAFbx mRNA and MuRF1 mRNA are elevated 60-120 min after myotube exposure to either IL-1 alpha or IL-1 alpha. These responses are preceded by signaling events that promote E3 expression. Both IL-1 isoforms stimulate phosphorylation of p38 mitogen-activated protein kinase and stimulate nuclear factor-kappa B (NF-kappa B) signaling; I-kappa B levels fall and NF-kappa B DNA binding activity increases. Other regulators of E3 expression are unaffected by IL-1 [ cytosolic oxidant activity, Fork-head-O (Foxo) activity] or respond paradoxically (AKT). Chronic exposure of C2C12 myotubes over 48 h resulted in reduced myotube width and loss of sarcomeric actin. We conclude that IL-1 alpha and IL-1 beta act via an oxidant-and AKT/Foxo-independent mechanism to activate p38 MAPK, stimulate NF-kappa B signaling, increase expression of atrogin1/MAFbx and MuRF1, and reduce myofibrillar protein in differentiated myotubes.